Celgene Corp (NASDAQ:CELG)

114.75
Delayed Data
As of Apr 20
 +1.28 / +1.13%
Today’s Change
68.38
Today|||52-Week Range
129.06
+2.58%
Year-to-Date

Today’s Trading

Previous close113.47
Today’s open114.40
Day’s range113.03 - 114.77
Volume4,487,201
Average volume (3 months)5,444,985
Market cap$90.8B
Dividend yield--
Data as of 04/20/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+29.83%
Earnings growth (next 5 years)+23.49%
Revenue growth (last year)+17.89%
P/E ratio48.0
Price/Sales11.75
Price/Book13.92

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.23+0.32%
ABBVAbbVie+1.25+2.01%
LLYEli Lilly and Co-0.06-0.08%
BMYBristol-Myers Squibb+0.51+0.78%
Data as of 04/20/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$1.06
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers